Cytek Biosciences(CTKB)
FREMONT, CABiotechnology
Focus: Cytek Biosciences is a public biotechnology company specializing in flow cytometry instruments and solutions for research and clinical diagnostics. The company operates at mid-cap scale with $193M in FY 2025 revenue and serves the life sciences instrumentation market.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
20
Should You Work at Cytek Biosciences?
AI assessmentCytek represents a stable mid-cap instrumentation play with growth momentum, but profitability headwinds and modest hiring suggest this is a consolidation rather than hypergrowth phase.
Why Work Here
- Public company status provides equity upside potential and career stability with established cash position of $99M
- Growing revenue trajectory (+17.7% YoY from $164M to $193M) signals market traction and expansion opportunities
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$193M
Key Products
Flow Cytometry Systems
Growing
Growth
Core product portfolio driving $193M annual revenue with continued market adoption in metabolic disease and broader research applications.
Recent News · Cytek Biosciences(6)
Help build intelligence for Cytek Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.